Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance.
Clinical Benefit
| Substantial |
The transparency Committee considers that the actual benefit of ARAVA continues to be substantial in the indications in the Marketing Authorisation. |
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
rqXSUPTf7dAB9ZPC
Listen
